Back to search

Article

Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseases

2020-03-13

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Evidence for the association between glucocorticoid dose and cardiovascular risk is weak for moderate and low doses. To quantify glucocorticoid dose-dependent cardiovascular risk in people with six immune-mediated inflammatory diseases. <h4>Methods and Findings</h4> Population-based cohort analysis of medical records from 389 primary care practices contributing data to the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e8eab0a-cb96-5020-be7c-10d860fcf3b7
DOI
10.1101/2020.03.11.20034157
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseasesDOI 10.1101/2020.03.11.20034157
The impact of TNF inhibitors on glucocorticoid use among patients with inflammatory arthritides: A nationwide cohort studySemantic proximity
Common comorbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK BiobankSemantic proximity
Comparative Cardiovascular Risk Index Across Autoimmune Conditions in a Large Middle-East Health SystemSemantic proximity
Anakinra in the Management of Adult-Onset Still’s Disease: A Single-Center ExperienceSemantic proximity
Cardiovascular Health, Genetic Susceptibility, and the Risk of Incident Autoimmune Disorders in the UK Biobank: A Prospective Cohort Study.Semantic proximity
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseasesSemantic proximity
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity
Allostatic load elevates the risk and adverse prognosis of immune-mediated inflammatory diseases: modulatory effects of lifestyle interventions and genetic susceptibility.Semantic proximity
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity
Pharmacoepidemiology of autoimmune diseasesSemantic proximity
How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity
Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithmSemantic proximity
Select a neighboring publication to make it the new centre.